Related Experiment Video
Updated: May 12, 2026
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
MicroRNA genetic variations: association with type 2 diabetes
Cinzia Ciccacci1, Davide Di Fusco, Laura Cacciotti
1Department of Biomedicine and Prevention, Genetics Section, University of Rome "Tor Vergata", Via Montpellier 1, 00133, Rome, Italy.
Acta Diabetologica
|March 28, 2013
Summary
Genetic variations in microRNA (miRNA) genes are linked to type 2 diabetes (T2DM) risk. Specific miRNA polymorphisms show protective or risk effects, suggesting a role in T2DM pathogenesis.
Area of Science:
- Genetics
- Molecular Biology
- Endocrinology
Background:
- MicroRNAs (miRNAs) are key genomic regulators involved in metabolism and glucose homeostasis.
- Dysregulation of miRNAs is implicated in metabolic disorders, including type 2 diabetes (T2DM).
Purpose of the Study:
- To investigate whether genetic variations in candidate microRNA genes contribute to T2DM susceptibility.
- To identify specific miRNA polymorphisms associated with T2DM risk in an Italian cohort.
Main Methods:
- Selected 13 candidate miRNA loci based on literature and computational analysis.
- Analyzed miRNA genes via direct sequencing in 163 T2DM patients and 185 healthy controls.
- Performed case/control association studies on identified single nucleotide polymorphisms (SNPs).
Main Results:
- Identified 6 novel variants and 9 known SNPs in miRNA genes.
- Found five novel variants exclusively in the T2DM cases group.
- rs895819 (hsa-mir-27a) G allele showed a protective effect (OR=0.58, P=0.008); rs531564 (hsa-mir-124a) G allele indicated a risk (OR=2.15, P=0.008).
Conclusions:
- Genetic polymorphisms within miRNA regions can influence T2DM susceptibility.
- This study provides the first evidence linking miRNA gene variations to T2DM risk.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...